Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 700 of 1631 entries
View as:

Belgian Real Life Non-interventional Study (NIS) on Xarelto in Non-valvular Atrial Fibrillation (AF) Patients Treated for the Prevention of Stroke and Systemic Embolism

Phase: N/A Priority: Normal
NCT ID: NCT01855139 Org: User:
Start: 07/31/13 End: 12/31/14 Due: 12/31/15

Study to Assess the Dietary Carbohydrate Content of Indian Diabetics With Special Therapeutic View on Effectiveness of Acarbose and Metformin Monotherapy

Phase: N/A Priority: Normal
NCT ID: NCT01961388 Org: User:
Start: 08/31/15 End: 06/30/17 Due: 06/30/18

ZK-Epo Given With Prednisone in Patients With Metastatic Androgen-independent Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00350051 Org: User:
Start: 08/01/06 End: 12/21/09 Due: 12/21/10

Japanese BAY80-6946 Monotherapy Phase I Study

Phase: N/A Priority: Normal
NCT ID: NCT01404390 Org: User:
Start: 08/18/11 End: 07/12/12 Due: 07/12/13

Rivaroxaban Pharmacokinetics/Pharmacodynamics (PK/PD) Study in Pediatric Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01145859 Org: User:
Start: 11/30/10 End: 07/31/15 Due: 07/31/16

Clinical Study to Evaluate the Pharmacokinetics, Safety, Tolerability and Pharmacodynamic Effects of a Single Oral 10 mg BAY1101042 Tablet Dose in Men and Woman With Renal Impairment and in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03235076 Org: User:
Start: 08/15/17 End: 03/13/19 Due: 03/13/20

Long-term Treatment on BAY77-1931 (Lanthanum Carbonate) to Measure Lanthanum Concentrations in Bone

Phase: N/A Priority: Normal
NCT ID: NCT00767637 Org: User:
Start: 06/30/05 End: 10/31/08 Due: 10/31/09

Phase II Copanlisib in Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)

Phase: N/A Priority: Normal
NCT ID: NCT02391116 Org: User:
Start: 05/08/15 End: 01/19/18 Due: 01/19/19

Naproxen Sodium Extended-Release Actual Use Study

Phase: N/A Priority: Normal
NCT ID: NCT00751400 Org: User:
Start: 07/31/08 End: 11/30/08 Due: 11/30/09

BEYOND Follow-up: Betaferon®/Betaseron® Efficacy Yielding Outcomes of a New Dose

Phase: N/A Priority: Normal
NCT ID: NCT00459667 Org: User:
Start: 05/31/07 End: 03/31/08 Due: 03/31/09

Clinical Study to Evaluate the Maximum Tolerated Dose of BAY79-4620 Given Every 2 Weeks to Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01065623 Org: User:
Start: 04/30/10 End: 08/31/10 Due: 08/31/11

Trial to Evaluate the Effect of Secondary Prophylaxis With rFVIII Therapy in Severe Hemophilia A Adult and/or Adolescent Subjects Compared to That of Episodic Treatment

Phase: N/A Priority: Normal
NCT ID: NCT00623480 Org: User:
Start: 03/31/08 End: 11/30/13 Due: 11/30/14

Darolutamide in Addition to Standard Androgen Deprivation Therapy and Docetaxel in Metastatic Hormone-Sensitive Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02799602 Org: User:
Start: 11/30/16 End: 04/11/23 Due: 04/11/24

Study to Learn More About the Benefits and Side-effects of Drugs Rivaroxaban and Apixaban Compared to the Drug Warfarin for Stroke Prevention in Patients With Rapid and Irregular Heartbeat Which is Not Due to a Heart-valve Fault (Non-valvular Atrial Fibrillation) in the UK Routine Clinical Practice

Phase: N/A Priority: Normal
NCT ID: NCT03847181 Org: User:
Start: 02/28/19 End: 10/31/20 Due: 10/31/21

Real-world Comparative Effectiveness of Stroke Prevention in Patients With Atrial Fibrillation Treated With Rivaroxaban vs. Vitamin k Antagonists

Phase: N/A Priority: Normal
NCT ID: NCT02960880 Org: User:
Start: 10/15/16 End: 12/31/16 Due: 12/31/17

Effect of Neomycin on the Pharmacokinetics of Regorafenib

Phase: N/A Priority: Normal
NCT ID: NCT02001909 Org: User:
Start: 12/31/13 End: 04/30/14 Due: 04/30/15

BAY 1902607: Single Dose Escalation, Safety and Tolerability, Pharmacokinetics, Bioavailability, Food Effect

Phase: N/A Priority: Normal
NCT ID: NCT03212586 Org: User:
Start: 07/18/17 End: 07/27/18 Due: 07/27/19

A Study to Learn About How BAY2927088 Affects the Level of Midazolam in the Blood When Both Drugs Are Taken Together in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT06360211 Org: User:
Start: 04/17/24 End: 06/28/24 Due: 06/28/25

A Study to Assess Menstrual Cramp Pain Associated With Primary Dysmenorrhea

Phase: N/A Priority: Normal
NCT ID: NCT03448536 Org: User:
Start: 04/05/18 End: 09/05/18 Due: 09/05/19

A Research Called CREDIT Studies How Safe the Study Treatment Radium-223 is and How Well it Works in Chinese Men With Advanced Prostate Cancer That Has Spread to the Bones and Does Not Respond to Treatments for Lowering Testosterone Levels

Phase: N/A Priority: Normal
NCT ID: NCT05301062 Org: User:
Start: 09/15/22 End: 06/30/23 Due: 06/30/24

Ovulation Inhibition of Two 4-phasic Oral Contraceptive Regimens

Phase: N/A Priority: Normal
NCT ID: NCT00805415 Org: User:
Start: 03/31/03 End: 02/29/04 Due: 02/28/05

EYLEA [AMD-QOL(Age-Related Macular Degeneration-Quality of Life)] Post-marketing Surveillance in Japan

Phase: N/A Priority: Normal
NCT ID: NCT01756261 Org: User:
Start: 12/26/12 End: 02/27/17 Due: 02/27/18

Nifedipine (Adalat CR, BAY A1040) High Dose PK/PD Study

Phase: N/A Priority: Normal
NCT ID: NCT00768560 Org: User:
Start: 01/31/08 End: 05/31/08 Due: 05/31/09

Evaluation of ZK 6032924 in Probable Alzheimer's Disease Patients Versus Healthy Volunteers and the Radiation Dosimetry of ZK 6032924 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01035164 Org: User:
Start: 06/30/07 End: 01/31/10 Due: 01/31/11

An Observational Study to Learn More About How Safe Vericiguat is and How Well it Works in Indian People With Chronic Heart Failure With Reduced Ejection Fraction and Worsening Chronic Heart Failure Under Real World Conditions

Phase: N/A Priority: Normal
NCT ID: NCT06632483 Org: User:
Start: 08/01/25 End: 04/30/26 Due: 04/30/27